Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis

Año publicación: 2025

Subir documento: https://drive.google.com/drive/folders/1YDrr72eY2iwsmwbTlKLY6Ua2K1gexPyb?usp=drive_link

Nombre investigadores: Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær, Kasper Almholt, Kristian M. Bendtsen, Elisabetta Bugianesi, Kenneth Cusi, Elisabeth D. Galsgaard, Milan Geybels, Lise L. Gluud, Lea M. Harder, Rohit Loomba, Gianluca Mazzoni, Philip N. Newsome, Louise M. Nitze, Mads S. Palle, Vlad Ratziu, Anne-Sophie Sejling, Vincent W.-S. Wong, Quentin M. Anstee & Lotte B. Knudsen